How Azamian was paid
$6.6M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Bobak AzamianPresident, Chief Executive Officer and Board Chairman | $726,333 | $2,648,284 | $2,651,487 | $555,700 | $36,175 | $6,617,979 |
| Jeffrey FarrowChief Financial Officer and Chief Strategy Officer | $541,667 | $893,961 | $895,011 | $264,900 | $82,078 | $2,677,617 |
| Seshadri NeervannanChief Operating Officer | $547,000 | $893,961 | $895,011 | $267,300 | $24,900 | $2,628,172 |
| Aziz MottiwalaChief Commercial Officer | $529,250 | $983,361 | $984,518 | $260,100 | $32,300 | $2,789,529 |
| Bryan WahlGeneral Counsel | $500,833 | $893,961 | $895,011 | $245,500 | $24,900 | $2,560,205 |
What changed and why
- $451.4MNet product sales grew to $451.4 million in 2025 compared to $180.1 million in 2024.
- 3.4%Base salaries for named executive officers increased by 3.4% to 7.6% in March 2025.
- 60%Dr. Azamian's target annual bonus percentage increased from 60% to 70% of base salary.
- 108%The annual cash incentive program was funded at 108% based on corporate goal achievement.
- Special transformational performance-based RSUs were granted to executive officers for the first time.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.